ATHE

1.5208.16%
RC

Robert Cherny

Head of Research

Dr. Robert Cherny, Ph.D. has been the Head of Research of Alterity Therapeutics Limited (formerly known as Prana Biotechnology Limited). since April 23, 2007. In his laboratory at the Mental Health Research Institute in Melbourne, Dr. Cherny has been at the forefront of Prana's research activities for the past 10 years. He was a lead author on a number of pivotal publications establishing the basis for Prana's science, in particular the mechanism-of-action studies of PBT2.

Positions